MarginsXMarginsX
Home › Data Desk › Public offerings

Public offerings

Automated articles on Public offerings, built every day from SEC filings, prices and our own datasets.

All topics · Dilution · Offerings · Convertible notes · FDA approval · Licensing and milestone payments · At-the-market offering · Delistings · Mergers and acquisitions · Restaurants · Casinos · Foreign private issuer · Material weakness · Early-stage clinical trials · Oncology · FDA setbacks · Reverse split · Private placement (PIPE) · Warrants and inducements · Biofuels and renewable natural gas · Insider buying · Debt financing · Divestitures · Solar · Artificial intelligence · Equity line of credit · Late-stage clinical trials · Daily feature · Going-concern doubt · Week ahead · Customer concentration · Late filings · Weekly roundups · Rates and the dollar · Banking · Quarterly results · Dual-class shares · Inflation and interest rates · Share buybacks · AI data centers · Executive turnover · GPUs and accelerators · Big movers · IPO · Public offerings · SPAC · China exposure · Convertible preferred stock · Natural gas and LNG · Cryptocurrency · Bankruptcy · Tobacco and vaping · Related-party loans · Nasdaq deficiency notice · Payments and fintech · Alcoholic beverages · Oil and gas production · Delisting · Aerospace and aviation · Tariffs · Medical devices · 13G holders · Carbon and clean energy credits · Semiconductors · Cannabis · Electric vehicles · Name or ticker change · Aesthetics and dermatology · Pet products · Stablecoins · Critical minerals · Gold mining · Mineral exploration · Auditor changes · Drones · Cell and gene therapy · Defense and military · Exchange listing notices · OTC quotation · Battery energy storage · Authorized share increase · 13D stakes · Robotics · Market wrap · Dividend payments · Spin-offs · Carbon capture · Impairment charges · Firearms and ammunition · Reverse merger · Securities class actions · Generative AI · Layoffs and restructuring · Asset management and BDCs · Hydrogen and fuel cells · Joint ventures · REITs and real estate · Reverse splits · Data centers · Backlog and contracted revenue · Trucking and logistics · Agriculture · Wind power · Video games and esports · War and geopolitical risk · Insurance carriers · Medicare and Medicaid reimbursement

Going-concern doubt appears in Energy Transition Special Opportunities's 10-Q

Energy Transition Special Opportunities (ETSS) told investors in its 10-Q on Nov 10, 2026 that there is substantial doubt it can continue operating as a going concern. (SEC EDGAR, 10-Q, Nov 10, 2026)

November 14, 2026 · data as of 2026-11-10

Cartesian Growth Corporation IV's 10-Q carries going-concern doubt

In its 10-Q, filed Nov 13, 2026, Cartesian Growth Corporation IV (CGCF) disclosed substantial doubt that it can carry on as a going concern. (SEC EDGAR, 10-Q, Nov 13, 2026)

November 14, 2026 · data as of 2026-11-13

Talon Capital Corp. flags going-concern doubt in its 10-Q

Talon Capital Corp. (TLNC) told investors in its 10-Q on Nov 13, 2026 that there is substantial doubt it can continue operating as a going concern. (SEC EDGAR, 10-Q, Nov 13, 2026)

November 14, 2026 · data as of 2026-11-13

PepGen Inc. has about 4.2 months of cash at its recent burn

The 10-Q that PepGen Inc. (PEPG) filed on Nov 10, 2026 covers the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 10, 2026)

November 14, 2026 · data as of 2026-11-10

Ambiq Micro Inc. revenue rises 110.0% in the quarter to Sep 30, 2026

Ambiq Micro Inc. (AMBQ) filed its 10-Q on Nov 10, 2026, covering the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 10, 2026)

November 14, 2026 · data as of 2026-11-10

Insider buying at Orchestra BioMed Holdings Inc.: 5 buyers, $6.2M

Between Nov 9, 2026 and Nov 9, 2026, 5 insiders of Orchestra BioMed Holdings Inc. (OBIO) bought $6.2M of its shares in the open market, by their SEC filings. (SEC EDGAR, Form 4, Nov 9, 2026)

November 14, 2026 · data as of 2026-11-13

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Follow topics in MarginsX